Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EXCELLENT: Ultra-early Edaravone + Revascularization for Acute Ischemic Stroke
NCT07119021Phase 4Recruiting
- Start
- Aug 2024
- Primary completion
- Apr 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of edaravone in ischemic stroke. Started Aug 2024; status: recruiting.
02
Drugs
edaravone
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT07119021.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07119021.